Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness and safety of favipiravir compared to supportive care in moderately to critically ill COVID-19 patients: a retrospective study with propensity score matching sensitivity analysis.
Alamer A, Alrashed AA, Alfaifi M, Alosaimi B, AlHassar F, Almutairi M, Howaidi J, Almutairi W, Mohzari Y, Sulaiman T, Al-Jedai A, Alajami HN, Alkharji F, Alsaeed A, Alali AH, Baredhwan AA, Abraham I, Almulhim AS. Alamer A, et al. Among authors: howaidi j. Curr Med Res Opin. 2021 Jul;37(7):1085-1097. doi: 10.1080/03007995.2021.1920900. Epub 2021 May 19. Curr Med Res Opin. 2021. PMID: 33890544 Free PMC article.
Truncating mutations in YIF1B cause a progressive encephalopathy with various degrees of mixed movement disorder, microcephaly, and epilepsy.
AlMuhaizea M, AlMass R, AlHargan A, AlBader A, Medico Salsench E, Howaidi J, Ihinger J, Karachunski P, Begtrup A, Segura Castell M, Bauer P, Bertoli-Avella A, Kaya IH, AlSufayan J, AlQuait L, Chedrawi A, Arold ST, Colak D, Barakat TS, Kaya N. AlMuhaizea M, et al. Among authors: howaidi j. Acta Neuropathol. 2020 Apr;139(4):791-794. doi: 10.1007/s00401-020-02128-8. Epub 2020 Jan 31. Acta Neuropathol. 2020. PMID: 32006098 No abstract available.
Revitalizing oncology medications access in Saudi Arabia: Current challenges and recommendations by the Saudi Oncology Pharmacy Assembly.
Alkhudair N, Howaidi J, Alnuhait M, Alshamrani M, Khan M, Alharbi A, Alnajjar F, Bajnaid E, Almodaheem H, Alhowimel M, Alzahrani A, Khardaly A, Alnahedh M, Elsoudi H, Alabdulkareem H, Alrashidan A, Alzahrani M, Alrajhi A. Alkhudair N, et al. Among authors: howaidi j. J Oncol Pharm Pract. 2024 Feb 20:10781552241232697. doi: 10.1177/10781552241232697. Online ahead of print. J Oncol Pharm Pract. 2024. PMID: 38377985 Free article.
Cost-effectiveness of Favipiravir in moderately to severely ill COVID-19 patients in the real-world setting of Saudi arabian pandemic referral hospitals.
Alamer A, Almutairi AR, Halloush S, Al-Jedai A, Alrashed A, AlFaifi M, Mohzari Y, Almutairi M, AlHassar F, Howaidi J, Almutairi W, Abraham I, Alkhatib N. Alamer A, et al. Among authors: howaidi j. Saudi Pharm J. 2023 Apr;31(4):510-516. doi: 10.1016/j.jsps.2023.02.003. Epub 2023 Feb 15. Saudi Pharm J. 2023. PMID: 36819111 Free PMC article.